Ulli Lust is awarded the German Non-Fiction Prize 2025 for 'Die Frau als Mensch'
Statement from the jury:
'The strong woman as a human being. In her informed and imaginative non-fiction book on the origins of humanity – between evolution and culture – Ulli Lust reveals how the role of women in human history has remained largely invisible. A fundamental revision of the long-dominant image of 'man as mankind' is overdue, as this book demonstrates through its unique interweaving of scholarly insights from archaeology, anthropology, and art history, continually inspired by everyday experiences. With this multi-layered approach, Lust succeeds in breaking open long-held assumptions – including those about the genre of non-fiction itself, which she expands in the most beautiful way through her virtuoso combination of image and text.'
The members of the jury for the German Non-Fiction Prize 2025 are: Michael Hagner (ETH Zurich), Christiane Hoffmann (author), Michael Lemling ('Buchhandlung Lehmkuhl' bookshop), Manuela Lenzen (science journalist), Patricia Rahemipour (Institute for Museum Research, Prussian Cultural Heritage Foundation), Heike Schmoll (Frankfurter Allgemeine Zeitung) and Katrin Vohland (Natural History Museum Vienna).
The following books were also nominated for the award:
Ingo Dachwitz & Sven Hilbig,Digitaler Kolonialismus. Wie Tech-Konzerne und Großmächte die Welt unter sich aufteilen(C.H.Beck)
Aladin El-Mafaalani, Sebastian Kurtenbach & Klaus Peter Strohmeier, Kinder –Minderheit ohne Schutz. Aufwachsen in der alternden Gesellschaft(Kiepenheuer & Witsch)
Franz-Stefan Gady,Die Rückkehr des Krieges. Warum wir wieder lernen müssen, mit Krieg umzugehen(Quadriga)
Ines Geipel,Fabelland. Der Osten, der Westen, der Zorn und das Glück(S. Fischer)
Martina Heßler,Sisyphos im Maschinenraum. Eine Geschichte der Fehlbarkeit von Mensch und Technologie(C.H.Beck)
Walburga Hülk,Victor Hugo. Jahrhundertmensch(Matthes & Seitz Berlin)
Bernhard Kegel,Mit Pflanzen die Welt retten. Grüne Lösungen gegen den Klimawandel(DuMont)
The German Non-Fiction Prize is awarded by the Stiftung Buchkultur und Leseförderung des Börsenvereins des Deutschen Buchhandels (Foundation for Book Culture and the Promotion of Reading of the German Publishers and Booksellers Association) in recognition of an outstanding original German-language non-fiction book that inspires social debate.
The Deutsche Bank Stiftung (Deutsche Bank Foundation) is the main supporter of the prize, which is also backed by the City of Hamburg and Frankfurter Buchmesse. The cultural programme 'aspekte' on ZDF and Deutschlandfunk Kultur are media partners of the prize.
Apress photo of the winnerwill be available from approx. 8 p.m. at
www.boersenverein.de/pressefotos.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a day ago
- Business Wire
Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model
ERLANGEN, Germany & BERLIN--(BUSINESS WIRE)--The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time, the damaged connections between the auditory nerve and inner ear sensory cells were restored. These findings were recently published in the prestigious International Journal of Molecular Sciences in a joint study conducted by Erlangen University Hospital and Berlin-based drug developer AudioCure. As there is currently no causal treatment for tinnitus, there is a high medical need. AC102 regenerates connections between the inner ear and auditory nerve in a preclinical model and eliminates tinnitus. Efficacy of AC102 on sudden hearing loss and tinnitus currently investigated in clinical trial. Share In the current study, AC102 was administered to the middle ear of one experimental group after acoustic trauma, while a second group received a placebo. Although both groups initially showed signs of tinnitus, they nearly disappeared in the AC102 group after five weeks – in clear contrast to the placebo group. Additionally, the AC102 group showed significantly less loss of synaptic connections between the inner ear and the auditory nerve than the placebo group. This damage is considered to be a potential cause of tinnitus: 'Our results suggest regeneration of inner ear structures that are critical for tinnitus and could be an important milestone and a glimmer of hope for a causal treatment of tinnitus,' says the study's first author, Dr. Konstantin Tziridis from Erlangen University Hospital. About two-thirds of sudden hearing loss patients also suffer from tinnitus, which persists in around 30% of cases. Although 10-15% of adults experience tinnitus, no effective causal treatment exists. AC102 has the potential to become a new treatment option. In a preclinical acoustic trauma model, it almost completely reversed sudden hearing loss. Since tinnitus often accompanies sudden hearing loss, AudioCure is investigating AC102's potential efficacy also against tinnitus in its ongoing study. AudioCure's CEO, Dr. Reimar Schlingensiepen, emphasizes: "Constant ear noise caused by tinnitus can be even more stressful for many patients than the hearing loss itself. With AC102, we hope to eventually have an effective remedy for both conditions. This would be a great relief for patients and doctors who have no approved drug treatment available at present." AC102 has already been tested for safety and tolerability in a clinical study and is currently being examined in a Europe-wide Phase-2-study in patients for its effectiveness in sudden hearing loss and tinnitus.
Yahoo
24-06-2025
- Yahoo
Losing Our Voice: The Human Cost of AI-Driven Language
Losing Our Voice: The Human Cost of AI-Driven Language originally appeared on L.A. Mag. Not only is AI influencing our written communication, but it is also altering our verbal interactions. The Max Planck Institute for Human Development in Berlin has conducted research on the impact of ChatGPT on human speech by analyzing 280,000 academic YouTube videos. Since the release of ChatGPT in 2022, certain words have become more prevalent in everyday vocabulary, with terms such as 'delve,' 'meticulous,' 'realm,' and 'adept' being used 51% more frequently. Researchers at the Max Planck Institute for Human Development confirmed that ChatGPT favors these words to a greater extent than humans, as seen in a previous study comparing human- to AI-edited texts. The word 'delve' has proven to be a front runner in determining how speakers 'internalize this virtual vocabulary into daily communication,' according to Hiromu Yakura, the study's lead author and a are unaware of the shift in their language, but what's more concerning is how we sound. Despite research being primarily focused on vocabulary, there are suspicions that AI is beginning to shape our tone, with people speaking with more structure and less emotional expression. AI, a tool that seemingly improves our grammatical and structured communication, creates a divide in our collaborative communication through the suspicion it arouses. Mor Naaman, professor of Information Science at Cornell Tech has outlined three levels of human detachment caused by the adoption of virtual vocabulary. The first level is the loss of authenticity and vulnerability in our speech that proves our availability as human beings. The second level involves lessened attention and effort in our communication, relating to our level of care. The final level consists of our ability to show our real selves: our humor, our competence, or our regret. Naaman uses an example of texting someone, 'I'm sorry you're upset' versus 'Hey, sorry I freaked at dinner, I probably shouldn't have skipped therapy this week.' The distinction between a structured apology versus a personal explanation makes all the difference between ChatGPT and a real human being. We are losing the autonomy of our speech and the trust in our communication with others, and soon, we may lose agency over our thinking. 'Instead of articulating our own thoughts, we articulate whatever AI helps us to articulate…we become more persuaded,' Naaman says. Ultimately, our personhood is at stake. ChatGPT creates stereotypes about communities and what 'correct' English is. But, instead of adopting a homogeneous vocabulary and a 'correct' method of communication, we must self-regulate and celebrate the imperfections that build trust and make us human. This story was originally reported by L.A. Mag on Jun 23, 2025, where it first appeared.
Medscape
23-06-2025
- Medscape
One in Four Clinicians Battle Self-Medicated Insomnia
More than 25% of healthcare professionals in Spain experience moderate-to-severe insomnia and report using psychiatric or sleep-inducing medications that are often self-prescribed. These findings are from a recent study published in the Journal of Clinical Medicine and were presented at the 33rd Annual Meeting of the Spanish Sleep Society. From March 2023 to January 2024, researchers conducted an online, cross-sectional survey of 1121 healthcare professionals at the University of Salamanca Health Care Complex (CAUSA), Salamanca, Spain. They assessed the prevalence of insomnia among healthcare professionals, identified those needing clinical intervention, analyzed shift work as a potential risk factor, and explored associations with COVID-19 sequelae and psychiatric comorbidities. Carlos Roncero, MD, PhD, professor of psychiatry at the University of Salamanca, former head of the Addiction and Dual Diagnosis Unit at Hospital Vall d'Hebron in Barcelona, and president of the Spanish Society of Dual Pathology, told Medscape Spanish that 'Mental-health programs during the SARS-CoV-2 pandemic revealed widespread sleep disturbances among healthcare professionals, patients, and their families. So, the need to study post-pandemic sleep problems in healthcare workers was recognized, which led to initiation of the Mental Health Support Program and the psychiatry service provided care for COVID-19 patients, their families, and healthcare workers,' he said. The Study Overall, 22.7% of the participants reported moderate insomnia, and 3% reported severe insomnia. Nearly 30% of the respondents screened positive for depression (28.4%) or anxiety (33%). 'We have not observed major disparities based on professional role. However, there are differences by gender and age: Women tend to report more sleep problems, and insomnia is more common among older individuals. Prior COVID-19 infection, shift work, and coexisting mental health conditions such as depression or anxiety also contribute.' Said Roncero regarding possible differences in prevalence based on the healthcare profession. The study specifically found that the risk for insomnia was 3.1 times higher among healthcare workers who had contracted COVID-19 and experienced after-effects — a finding the authors described as highly significant. Regarding whether this impact on sleep has persisted or diminished over time, Roncero explained, 'Our study is cross-sectional, but previous studies showed even higher rates of sleep disorders, so we assume that this problem has decreased. However, it is possible that the prevalence detected already has a 'floor effect,' so they will not decrease further if specific actions are not implemented.' Underdiagnosis and Self-Prescribing The high rate of underdiagnosis of this condition is also notable. Only 3.1% of the total population had sleep disorder traits. This frequency seems low, considering the negative impact of insomnia on productivity and cognitive functioning in the medical profession. 'More than 25% of health professionals have sleep problems, particularly insomnia. However, few patients are receiving treatment for this problem, and approximately 30% are receiving medication. There are several factors: on the one hand, the lack of recognition of insomnia and other sleep disorders as symptoms or a significant problem. On the other hand, there is little fear of self-medication with hypnotics. In this sense, the lack of awareness of the need to seek help and, therefore, to be diagnosed and treated is a problem that must be addressed,' Roncero said. Roncero also highlighted the high prevalence of psychiatric or sleep-aid medication use among this group. Specifically, 23.3% of healthcare workers reported taking medication at least once a month to help with their sleep problems. 'This is an important finding, given that it is higher than that of the general population. Therefore, it is essential that healthcare professionals receive support when taking these medications, something that does not always occur. In fact, in 27% of cases, these medications are self-prescribed by healthcare workers themselves, so they cannot be monitored by another professional who can objectively assess their need, dosage, and treatment duration,' he said. Measures María José Martínez, PhD coordinator of the Chronobiology Working Group of the Spanish Sleep Society, shared a similar perspective, although she was not involved in the study. In a statement to Medscape Spanish , she described the high rate of medication use and self-prescription as a 'worrying warning sign,' citing the risk of 'chronicizing insomnia and promoting tolerance and dependence without addressing the circadian origin of the problem.' 'Therefore, specific sleep hygiene education programs should be implemented, along with access to nonpharmacological interventions such as cognitive behavioral therapy for insomnia, and counseling on chronobiology applied to shift work. Furthermore, it is urgent to create confidential and accessible psychological care pathways for healthcare professionals, particularly following the COVID-19 pandemic,' she emphasized. The study confirmed that psychiatric comorbidities and sleep problems were more prevalent among shift and on-call workers and aligned with existing evidence that points to shift work as a major aggravating factor for insomnia. Extended hours and high-pressure conditions, particularly long shifts, are stressful circumstances that affect resilience and mental health outcomes among healthcare workers. 'This study reinforces and extends previous evidence, showing that shift work — particularly with frequent rotations — is associated with a significantly higher prevalence of insomnia and poor sleep quality in healthcare professionals,' Martínez said. 'Although we already knew that circadian desynchronization is a key factor, this study quantifies the impact in a real-life setting and with a representative sample of different healthcare profiles. Furthermore, it highlights the cumulative burden this chronic sleep disturbance places on a group already vulnerable due to their work and emotional demands,' she added. Martínez outlined the serious consequences of sleep problems among shift workers, noting increased risks for metabolic, cardiovascular, immune, and psychiatric disorders, including depression and anxiety. 'From a cognitive and functional perspective, lack of sleep reduces sustained attention, decision-making, and the ability to respond flexibly to complex clinical situations, which can compromise patient safety and increase the risk for errors. Added to this is the fact that accumulated fatigue diminishes motivation and promotes burnout,' she explained. 'All this evidence should prompt reflection on the detection, evaluation, and diagnostic processes we have implemented in the various healthcare centers,' Roncero stated. 'Insomnia and sleep impairment continue to be normalized as 'part of the job' in hospital culture. At the institutional level, it is key to recognize sleep as a pillar of occupational health and clinical safety,' Martínez said. She noted that while awareness is growing among medical professionals and institutions, it remains insufficient. Martínez and Roncero emphasized the need to implement measures in this regard. Martínez proposed several practical measures that should be adopted: 'Restructure shifts to align with circadian rhythms by avoiding rapid rotations and back-to-back night shifts; train human resources professionals in chronobiology; and implement real rest policies, including for residents. Sleep should also be a standard component of occupational health evaluations.' When asked whether follow-up studies are planned, Roncero said, 'We are currently assessing benzodiazepine use in this population and exploring the need for early detection and support programs for professionals with sleep disorders. We are also examining how these sleep problems are associated with professional development and personal repercussions. Carlos Roncero and María José Martínez declared having no relevant financial conflicts of interest.
